The University of Chicago Header Logo

Connection

John Edward A. Blair to Humans

Back to Details
This is a "connection" page, showing publications John Edward A. Blair has written about Humans.
John Edward A. Blair
Connection Strength
0.615
Humans
  1. Concomitant Lower-Extremity Deep Vein Thrombosis in Patients With Pulmonary Embolism Undergoing Catheter-Directed Therapy. J Invasive Cardiol. 2021 Nov; 33(11):E910-E915.
    View in: PubMed
    Score: 0.027
  2. Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction. J Invasive Cardiol. 2021 Jul; 33(7):E507-E515.
    View in: PubMed
    Score: 0.027
  3. Use of Prospective Radiobrachial Angiography in Transradial Cardiac Catheterization and Intervention. Cardiovasc Revasc Med. 2020 06; 21(6):797-803.
    View in: PubMed
    Score: 0.024
  4. Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2019 10; 25(10):843-845.
    View in: PubMed
    Score: 0.024
  5. A STEMI Mimic. N Engl J Med. 2019 May 30; 380(22):e41.
    View in: PubMed
    Score: 0.023
  6. Advanced Hybrid Complete Revascularization with TECAB and Impella-Assisted PCI of CTO. Cardiovasc Revasc Med. 2019 Nov; 20(11S):51-54.
    View in: PubMed
    Score: 0.023
  7. Broken arrow: Successful retrieval of a dislodged coronary orbital atherectomy microtip. Catheter Cardiovasc Interv. 2018 09 01; 92(3):511-514.
    View in: PubMed
    Score: 0.022
  8. Electronic cardiac arrest triage score best predicts mortality after intervention in patients with massive and submassive pulmonary embolism. Catheter Cardiovasc Interv. 2018 08 01; 92(2):366-371.
    View in: PubMed
    Score: 0.021
  9. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018 05 01; 314(5):H1033-H1042.
    View in: PubMed
    Score: 0.021
  10. Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report. ESC Heart Fail. 2017 11; 4(4):645-648.
    View in: PubMed
    Score: 0.020
  11. Diastolic Function and Transcatheter Aortic Valve Replacement. J Am Soc Echocardiogr. 2017 Jun; 30(6):541-551.
    View in: PubMed
    Score: 0.020
  12. Heart Failure With Preserved Ejection Fraction: Have We Finally Found the Perfect Noninvasive Biomarker? Circ Cardiovasc Imaging. 2016 12; 9(12).
    View in: PubMed
    Score: 0.019
  13. Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary Embolism. J Invasive Cardiol. 2016 May; 28(5):E49-51.
    View in: PubMed
    Score: 0.019
  14. Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement. Am J Cardiol. 2016 Feb 15; 117(4):633-639.
    View in: PubMed
    Score: 0.018
  15. Assessment of coronary blood flow in the cardiac catheterization laboratory. Curr Probl Cardiol. 2014 Jun; 39(6):159-84.
    View in: PubMed
    Score: 0.016
  16. Heart failure in North America. Curr Cardiol Rev. 2013 May; 9(2):128-46.
    View in: PubMed
    Score: 0.015
  17. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72.
    View in: PubMed
    Score: 0.013
  18. Regression of cardiac amyloid after autologous stem-cell transplantation. J Heart Lung Transplant. 2009 Jul; 28(7):746-8.
    View in: PubMed
    Score: 0.012
  19. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul; 30(13):1666-73.
    View in: PubMed
    Score: 0.011
  20. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.
    View in: PubMed
    Score: 0.011
  21. Usefulness of hand-carried ultrasound to predict elevated left ventricular filling pressure. Am J Cardiol. 2009 Jan 15; 103(2):246-7.
    View in: PubMed
    Score: 0.011
  22. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 2008 May-Jun; 15(3):231-40.
    View in: PubMed
    Score: 0.011
  23. Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome. Acute Card Care. 2007; 9(4):207-13.
    View in: PubMed
    Score: 0.010
  24. Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 19; 82(12):1245-1263.
    View in: PubMed
    Score: 0.008
  25. Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 19; 82(12):1264-1279.
    View in: PubMed
    Score: 0.008
  26. A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail. 2021 10; 8(5):3495-3503.
    View in: PubMed
    Score: 0.007
  27. Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail. 2021 10; 27(10):1045-1052.
    View in: PubMed
    Score: 0.007
  28. Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial. ESC Heart Fail. 2021 04; 8(2):1522-1530.
    View in: PubMed
    Score: 0.007
  29. Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease. Vascular. 2021 Jun; 29(3):355-362.
    View in: PubMed
    Score: 0.006
  30. Impact of Loop Diuretic Use on Outcomes Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 09 15; 131:67-73.
    View in: PubMed
    Score: 0.006
  31. Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening. Expert Opin Ther Targets. 2020 01; 24(1):47-62.
    View in: PubMed
    Score: 0.006
  32. Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2019 Dec 01; 94(7):1028-1033.
    View in: PubMed
    Score: 0.006
  33. Quantitative detection of changes in regional wall motion using real time strain-encoded cardiovascular magnetic resonance. Magn Reson Imaging. 2020 02; 66:193-198.
    View in: PubMed
    Score: 0.006
  34. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease. Exp Physiol. 2019 09; 104(9):1343-1352.
    View in: PubMed
    Score: 0.006
  35. Percutaneous Transapical Left Ventricular Access to Treat Paravalvular Leak and Ventricular Septal Defect. J Invasive Cardiol. 2019 Sep; 31(9):247-252.
    View in: PubMed
    Score: 0.006
  36. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 04 16; 139(16):e840-e878.
    View in: PubMed
    Score: 0.006
  37. Percutaneous Coronary Intervention following Placement of Sutureless Aortic Bioprostheses. Innovations (Phila). 2019 Apr; 14(2):177-182.
    View in: PubMed
    Score: 0.006
  38. Cost-utility of extracorporeal cardiopulmonary resuscitation in patients with cardiac arrest. Resuscitation. 2019 03; 136:126-130.
    View in: PubMed
    Score: 0.006
  39. Diagnosis of Isolated Cleft Mitral Valve Using Three-Dimensional Echocardiography. J Am Soc Echocardiogr. 2018 11; 31(11):1161-1167.
    View in: PubMed
    Score: 0.005
  40. Peak left atrial strain as a single measure for the non-invasive assessment of left ventricular filling pressures. Int J Cardiovasc Imaging. 2019 Jan; 35(1):23-32.
    View in: PubMed
    Score: 0.005
  41. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation. Int J Cardiovasc Imaging. 2018 Oct; 34(10):1607-1617.
    View in: PubMed
    Score: 0.005
  42. Mechanical chest compressions improve rate of return of spontaneous circulation and allow for initiation of percutaneous circulatory support during cardiac arrest in the cardiac catheterization laboratory. Resuscitation. 2017 06; 115:56-60.
    View in: PubMed
    Score: 0.005
  43. 3D echocardiographic analysis of aortic annulus for transcatheter aortic valve replacement using novel aortic valve quantification software: Comparison with computed tomography. Echocardiography. 2017 May; 34(5):690-699.
    View in: PubMed
    Score: 0.005
  44. Catheter-Directed Fibrinolysis of Submassive Pulmonary Embolism After IVC Filter Migration to Renal Veins. J Invasive Cardiol. 2017 Jan; 29(1):E8-E9.
    View in: PubMed
    Score: 0.005
  45. Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. J Card Fail. 2016 Aug; 22(8):653-5.
    View in: PubMed
    Score: 0.005
  46. Upper extremity vascular complications following transradial approach for cardiac catheterization and intervention: a focused review of diagnostic, prognostic and therapeutic considerations. Minerva Cardioangiol. 2016 Dec; 64(6):648-61.
    View in: PubMed
    Score: 0.005
  47. Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol. 2016 Apr; 28(4):133-8.
    View in: PubMed
    Score: 0.005
  48. Intraoperative coronary artery dissection in fibromuscular dysplasia. Ann Thorac Surg. 2015 Apr; 99(4):1442-4.
    View in: PubMed
    Score: 0.004
  49. Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation. Catheter Cardiovasc Interv. 2015 Apr; 85(5):828-31.
    View in: PubMed
    Score: 0.004
  50. Transradial cardiac catheterization in liver transplant candidates. Am J Cardiol. 2014 May 15; 113(10):1634-8.
    View in: PubMed
    Score: 0.004
  51. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. J Cardiovasc Med (Hagerstown). 2012 Jul; 13(7):415-22.
    View in: PubMed
    Score: 0.004
  52. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May; 159(5):841-849.e1.
    View in: PubMed
    Score: 0.003
  53. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May; 12(5):423-33.
    View in: PubMed
    Score: 0.003
  54. Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients referred for right heart catheterization. J Card Fail. 2010 Jan; 16(1):69-75.
    View in: PubMed
    Score: 0.003
  55. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009 Sep; 158(3):437-43.
    View in: PubMed
    Score: 0.003
  56. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009 Sep; 30(18):2233-40.
    View in: PubMed
    Score: 0.003
  57. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
    View in: PubMed
    Score: 0.003
  58. Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? Heart Fail Rev. 2009 Dec; 14(4):277-87.
    View in: PubMed
    Score: 0.003
  59. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. JACC Cardiovasc Imaging. 2008 Sep; 1(5):595-601.
    View in: PubMed
    Score: 0.003
  60. Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design. Heart Fail Rev. 2009 Jun; 14(2):101-12.
    View in: PubMed
    Score: 0.003
  61. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
    View in: PubMed
    Score: 0.003
  62. Aldosterone receptor blockade in patients with left ventricular systolic dysfunction following acute myocardial infarction. Cardiol Clin. 2008 Feb; 26(1):91-105, vii.
    View in: PubMed
    Score: 0.003
  63. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr. 2007 Jul; 20(7):857-61.
    View in: PubMed
    Score: 0.003
  64. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest. 2007 May; 131(5):1301-7.
    View in: PubMed
    Score: 0.003
  65. A comparison by medicine residents of physical examination versus hand-carried ultrasound for estimation of right atrial pressure. Am J Cardiol. 2007 Jun 01; 99(11):1614-6.
    View in: PubMed
    Score: 0.002
  66. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol. 2006 Jul; 1(4):749-53.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.